![Curing AIDS: After antiretrovirals brought the disease under control, a more ambitious goal is now in sight - San Francisco Business Times Curing AIDS: After antiretrovirals brought the disease under control, a more ambitious goal is now in sight - San Francisco Business Times](https://media.bizj.us/view/img/11052946/brainarddianacihlartomas091418tj-11-web*750xx1200-677-0-87.jpg)
Curing AIDS: After antiretrovirals brought the disease under control, a more ambitious goal is now in sight - San Francisco Business Times
![Antonin Holy,český vědec,učitel Tomase Cihlare/Czech scientists,teacher Tomas Cihlar,Coronavirus - YouTube Antonin Holy,český vědec,učitel Tomase Cihlare/Czech scientists,teacher Tomas Cihlar,Coronavirus - YouTube](https://i.ytimg.com/vi/d215idic8sc/sddefault.jpg)
Antonin Holy,český vědec,učitel Tomase Cihlare/Czech scientists,teacher Tomas Cihlar,Coronavirus - YouTube
Balasubramaniam on Twitter: "Tomas Cihlar, Vice President of Virology, Gilead Sciences describing the early scientific response to the HIV pandemic. @WIPO @TrabancoMaica @MilaMaistat https://t.co/bfpvqe1KZF" / Twitter
Cytotoxicity of Antiviral Nucleotides Adefovir and Cidofovir Is Induced by the Expression of Human Renal Organic Anion Transport
![Carolina Nanoformulation Workshop, Nanomedicine Drug Delivery Symposium tops 800 virtual participants, largest turnout in 18 years - UNC Eshelman School of Pharmacy Carolina Nanoformulation Workshop, Nanomedicine Drug Delivery Symposium tops 800 virtual participants, largest turnout in 18 years - UNC Eshelman School of Pharmacy](https://pharmacy.unc.edu/wp-content/uploads/sites/1043/2020/09/Screen-Shot-2020-09-21-at-12.54.45-PM-e1600707345973-800x420.png)
Carolina Nanoformulation Workshop, Nanomedicine Drug Delivery Symposium tops 800 virtual participants, largest turnout in 18 years - UNC Eshelman School of Pharmacy
![Reply to Yan and Muller, “Single-Cell RNA Sequencing Supports Preferential Bioactivation of Remdesivir in the Liver” | Antimicrobial Agents and Chemotherapy Reply to Yan and Muller, “Single-Cell RNA Sequencing Supports Preferential Bioactivation of Remdesivir in the Liver” | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/AAC.01394-21/asset/1416cdc8-8b6d-430e-b87d-4310dd36a81f/assets/aac.01394-21.fp.png)
Reply to Yan and Muller, “Single-Cell RNA Sequencing Supports Preferential Bioactivation of Remdesivir in the Liver” | Antimicrobial Agents and Chemotherapy
![Africa CDC on Twitter: "2nd day of the #EbolaConference2019. Dr Tomas Cihlar, Vice-president of @GileadSciences presented on Availability and Access to #Remdesivir for #Ebola virus disease Treatment. https://t.co/6zdpdImXQe" / Twitter Africa CDC on Twitter: "2nd day of the #EbolaConference2019. Dr Tomas Cihlar, Vice-president of @GileadSciences presented on Availability and Access to #Remdesivir for #Ebola virus disease Treatment. https://t.co/6zdpdImXQe" / Twitter](https://pbs.twimg.com/media/Dz_3XMgWkAAfWV1.jpg)